Company Filing History:
4 out of 16 
2 out of 28 Years Active: 2017-2023
Title: Innovations of Adam Vigil in Antibody Therapeutics
Introduction
Adam Vigil, an accomplished inventor based in Yonkers, NY, has made significant contributions to the field of therapeutic antibody applications. With a total of four patents, Vigil has focused on innovations that enhance the efficacy of treatments for viral infections, notably influenza.
Latest Patents
One of Vigil's latest inventions involves compositions and methods based on neutralizing antibodies that are delivered intranasally for enhanced therapeutic efficacy. This invention provides methods for the treatment or prophylaxis of viruses, particularly the influenza virus, through the administration of agents directly to the respiratory tract. The patent details the use of intranasal or inhalation methods, offering compositions suitable for these routes of administration. Additionally, Vigil has developed methods that combine these approaches with intraperitoneal or intravenous antibody administration.
Another notable patent focuses on antibodies useful for passive influenza immunization. This includes a range of antibodies and antigen-binding fragments that target the hemagglutinin cleavage site consensus sequence of influenza. His work on antibody compositions and methods emphasizes effective immunization strategies across various strains of influenza A and B.
Career Highlights
Vigil has a distinguished career, with experience at notable companies such as Contrafect Corporation and Trellis Bioscience, Inc. His work within these organizations has allowed him to advance his research in therapeutic applications and to innovate solutions that address significant public health challenges.
Collaborations
Adam Vigil has collaborated with talented individuals in his field, including Michael Wittekind and Angeles Estelles. These partnerships have been instrumental in the development of his innovative patents, allowing for an exchange of ideas and collaborative efforts that enhance the quality and impact of their work.
Conclusion
In summary, Adam Vigil is a prominent inventor whose work in antibody-based therapeutics significantly contributes to the fight against viral infections like influenza. His innovative patents reflect a deep understanding of the mechanisms of immunity and a commitment to improving treatment methodologies. As he continues to push the boundaries of science, Vigil's contributions will undoubtedly play a vital role in the advancement of medical therapies.